![](https://www.elaia.com/wp-content/uploads/2019/05/sc_logo_1.1_Plan-de-travail-1-2.png)
Sim&Cure develops the medical software Sim&Size® to optimize the choice of endovascular devices for the treatment of cerebral aneurysm. Sim&Size® is marked CE.
Entrepreneurs
Mathieu Sanchez
Vincent Costalat
Elaia Team
Related articles
![](https://www.elaia.com/wp-content/uploads/2019/05/sc_logo_1.1_Plan-de-travail-1-2.png)
Sim&Cure, leading medtech start-up proving unique digital solutions to secure neurovascular treatment of cerebral aneurysm, announces a 3M funding round led by Elaia with IT Translation.
2019.05.23 / 3min read.